Evaluation of CO-OP for Adolescents With Mild Intellectual Disability
NCT ID: NCT06691698
Last Updated: 2025-08-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2025-01-16
2027-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of the project is to describe and evaluate CO-OP for adolescents with mild ID. Participants will be adolescents aged 13-17 and their parents. The project is designed as a feasibility study with two qualitative, one quantitative and one mixed method data collection. The quantitative data will be ordinal and nominal data from observational and self-assessment assessments. The mixed methods include comparison between filmed sessions and the CO-OP manual, use of field notes to analyse fidelity and needs for adaptations, and comparison between the CO-OP manual and policy documents. The qualitative outcome will be experiences by the adolescents and perceptions of CO-OP by parents.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Participation of Autistic Children and Adolescents in the Habilitation Process
NCT06381856
Cognitive Orientation to Daily Occupational Performance and Conductive Education Approaches on Down Syndrome
NCT03687619
Dog Assisted Therapy Program for Children With ADHD
NCT06496685
The Swedish Versions of ADOS and ADI-R: Psychometric Validation
NCT01854333
Effects of Animal-assisted Therapy on the Physical Function and Communication of Adults With Autism
NCT04859998
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CO-OP for adolescents with mild intellectual disability
CO-OP intervention during 10 weeks. Outcomes measures at baseline, directly after and 6 months after intervention
The Cognitive Orientation to Daily Occupational Performance Approach
CO-OP is a client-centred, performance-based, problem-solving focused, occupation-focused and occupation-based intervention. In CO-OP the person is guided to use a meta-cognitive strategy to find his or her own strategies for specific activities. The main purpose is to enable meta-cognitive thinking in every day activities, leading to enhanced self-efficacy, occupational performance and independency.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
The Cognitive Orientation to Daily Occupational Performance Approach
CO-OP is a client-centred, performance-based, problem-solving focused, occupation-focused and occupation-based intervention. In CO-OP the person is guided to use a meta-cognitive strategy to find his or her own strategies for specific activities. The main purpose is to enable meta-cognitive thinking in every day activities, leading to enhanced self-efficacy, occupational performance and independency.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed mild intellectual disability
* Motivation to reach self-selected goals
* Ability to identify those goals
* Possibility to meet once a week for ten weeks
* Access to a parent or significant other for support during intervention
* 13-17 years
* Diagnosed mild intellectual disability
* Completed CO-OP intervention or at lest half way trough the intervention
* Opportunity to meet physically for an interview with in a month post and 6 months post intervention.
* CO-OP intervention done with high fidelity to CO-OP format with a CO-OP therapist that has written field notes, preferrably recruited from study I-II.
* Opportunity to meet physically for an interview with in a month post and 6 months post the adolescent's completed, or at least half way through, CO-OP intervention.
Exclusion Criteria
* Diagnosed attention deficit hyperactivity disorder/attention deficit disorder (ADHD/ADD) or autism spectrum disorder
* Progressive diagnoses
* Need for language interpreting
* Need for alternative and augmentative communication (i.e. pictures or signs).
Study III
* Movement related diagnosis (i.e. cerebral palsy or neuro muscular diseases)
* Diagnosed attention deficit hyperactivity disorder/attention deficit disorder (ADHD/ADD) or autism spectrum disorder
* Progressive diagnoses
* Need for language interpreting
* Need for alternative and augmentative communication (i.e. pictures or signs).
Study IV
* Need for language interpreting
* Need for alternative and augmentative communication (i.e. pictures or signs)
* Irregular and brief living with the adolescent comparable to less than half-time and therefore does not observe the adolescent's occupational performance enough to answer the interview questions.
13 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Landstinget i Värmland
OTHER
Göteborg University
OTHER
Stiftelsen Sunnerdahls Handikappfond
OTHER
Stiftelsen Sävstaholm
UNKNOWN
Majblommans riksförbund
UNKNOWN
Örebro University, Sweden
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marie Holmefur, PhD
Role: PRINCIPAL_INVESTIGATOR
Örebro University, Sweden
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Region Skåne
Kristianstad, Skåne County, Sweden
Region Värmland
Karlstad, Värmland County, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
Project presentation at Orebro University website.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ORU 2024-02873-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.